Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Plug and Play Launches Healthcare Innovation Program in Orlando
29 July 2025

Plug and Play Launches Healthcare Innovation Program in Orlando

Plug and Play New Healthcare Program in Orlando Announcement Plug and Play, a global innovation platform, will be launching a healthcare program in Orlando, Florida. Under the partnership with Orlando Health, KPMG LLP, and Guidewell, the program will be inviting around 10 to 12 startups in its...

Washington University in St. Louis and MilliporeSigma Partner to Boost Scientific Research and Innovation
29 July 2025

Washington University in St. Louis and MilliporeSigma Partner to Boost Scientific Research and Innovation

Washington University in St Louis and MilliporeSigma Appeared Together to Bolster Scientific Collaboration Announcement The Milliporesigma, the Canadian life science and the US business of Merck KGaA, Darmstadt, Germany, a popular technology and science company, entered into a contract, signin...

Xenetic Biosciences Expands CAR T-Cell Therapy R&D Partnership with Scripps Research
28 July 2025

Xenetic Biosciences Expands CAR T-Cell Therapy R&D Partnership with Scripps Research

Xenetic Biosciences to Extend R&D Agreement with the Scripps Research Institute Announcement Xenetic Biosciences Inc., a leading biopharmaceutical company popularly known for its innovative immune-oncology technologies to identify difficult oncology indications, has extended its collaborativ...

Global RDH12 Alliance and Opus Genetics Join Forces to Advance Gene Therapy for Childhood Vision Loss
28 July 2025

Global RDH12 Alliance and Opus Genetics Join Forces to Advance Gene Therapy for Childhood Vision Loss

Global RDH12 Alliance and Opus Genetics Entered a Partnership Agreement Announcement Global RDH12 alliance and Opus Genetics Inc., a biopharmaceutical company accelerating gene therapies for the treatment of small-molecule therapies and inherited retinal disease (IRDs) for other ophthalmic disor...

Tharimmune Launches $1.74 Million Public Offering with Common Stocks and Warrants
28 July 2025

Tharimmune Launches $1.74 Million Public Offering with Common Stocks and Warrants

Tharimmune’s Common Stocks and Warrants are Now Available for Purchase Announcement Tharimmune Inc. (Tharimmune and the company), a biotechnological company, a leader for therapies in inflammation and immunology, has revealed the price of its registered direct public offering with a few pu...

Caravan Biologix Partners with KOMO Biosciences to Advance Mini-CAR Cell Therapy Using KOMbine Platform
28 July 2025

Caravan Biologix Partners with KOMO Biosciences to Advance Mini-CAR Cell Therapy Using KOMbine Platform

Caravan Biologix Received a Research License for the KOMbine™ Platform Announcement KOMO Biosciences, a known precision genome engineering offered a research license to Caravan Biologix, a commendable innovator in advancing mini-CAR technology, and a miniature T-cell that holds the natural...

Kansai Startup Coalition Partners with Alloy Therapeutics to Boost Biotech Startups in Japan
25 July 2025

Kansai Startup Coalition Partners with Alloy Therapeutics to Boost Biotech Startups in Japan

Kansai and Alloy are in a Collaboration to Leverage Growth in Japan Announcement Kansai Startup Academia Coalition, represented by Kyoto University, fostered to expansion university university-affiliated life science startups throughout Japan, and Alloy Therapeutics co, Ltd. has signed a memoran...

QIAGEN Launches QIAseq xHYB Long-Read Panels to Improve Genomic Research
25 July 2025

QIAGEN Launches QIAseq xHYB Long-Read Panels to Improve Genomic Research

QIAGEN Enhances its Portfolio with Long-read Panels Announcement Qiagen has introduced new QIAseq xHYB long-read panels, a groundbreaking solution designed to explore the long-read sequencing of genomically complex regions. This sequencing idea strongly builds Qiagen’s position as a provid...

Hengrui and IDEAYA Biosciences to Present Promising Lung Cancer Drug Data at IASLC 2025
25 July 2025

Hengrui and IDEAYA Biosciences to Present Promising Lung Cancer Drug Data at IASLC 2025

Hengrui and IDEAYA Bioscience’s Publication for a Presentation at IASLC 2025 Announcement Jiangsu Hengrui Pharmaceuticals co ltd a pharmaceutical company known for its technological and scientific innovation, and IDEAYA Biosciences Inc., a global precision medicine oncology company, showca...

AAVnerGene and Klotho Neurosciences Partner to Advance Gene Therapy for Neurological Diseases
25 July 2025

AAVnerGene and Klotho Neurosciences Partner to Advance Gene Therapy for Neurological Diseases

AAVnerGene and Klotho’s Alliance Announcement AVVnerGene Inc., a Rockville, MD innovation-fueled biotech known for its remarkable technologies in AAV tissue-targeted delivery and manufacturing, and Klotho Neurosciences Inc. have entered a partnership to enhance the product’s potentia...